UFP Technologies reported record second-quarter 2026 results with sales of $173.96 million and net income of $20.85 million, both above prior-year levels. The stock has returned 22.61% over the past 90 days and 19.75% year to date, while the five-year total shareholder return stands at 319.98%. At a share price of $267.53, the company trades at a price-to-earnings ratio of 30.2 times, a premium to the Medical Equipment industry average of 29 times but 8.4% below one discounted cash flow-based fair value estimate of $292.16. Earnings have grown 28.2% annually over five years, though the forecast growth rate is a more moderate 12.46% per year and recent annual earnings growth was 8.1%.
UFP Technologies IncRecord Q2 results and earnings growth, with stock trading below DCF fair value.